Securities and Exchange Act B.E. 2535 (1992) as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008) which contains certain provisions relating to the restriction of rights and liberties of

1 No. CC20190504ELE May 14, 2019 Subject Report of the Resolutions of Board of Directors’ Meeting No.2/2019 To President The Stock Exchange of Thailand The Board of Directors’ meeting of Cal-Comp

No. WHAUP-CS014-2562 1 8 August 2019 Re Share Acquisition in Duong River Surface Water Plant JSC in Vietnam Dear President The Stock Exchange of Thailand WHA Utilities and Power Public Company

113 of the Securities and Exchange Act B.E. 2535 (1992) , as amended by the Securities and Exchange Act (No.4) B.E. 2551 (2008) , Section 100, Section 103(9) and (10), Section 109, Section 114, Section

Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No.4) B.E. 2551 (2008), Section 100, Section 103(9) and (10), Section 109, Section 114, Section 115, Section 116 and

nine-month period ending 30 September 2018 To The President The Stock Exchange of Thailand We, ZEN Corporation Group Public Company Limited (“the Group”), are please to inform you our management

IDH-AC-000-อส6302/30.00 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended 31 December 2019 To: President The Stock Exchange of Thailand Overview of the

Activities (332.76) (506.74) Unrealized exchange gain (loss) of cash and cash equivalents 0.03 (2.34) Cash Increase (Decrease) – Net 0.84 49.79 Cash at the Beginning of the Period 23.83 20.59 Cash at the

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as

(used in) Investing Activities (139.97) (91.53) Cash Flows from (used in) Financing Activities (369.59) (724.51) Unrealized exchange gain (loss) of cash and cash equivalents (0.62) (3.18) Cash Increase